An Open Trial of Metacognitive Therapy for Anxiety and Depression in Cancer

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
AnxietyDepressionCancer
Interventions
BEHAVIORAL

Metacognitive Therapy

MCT helps patients to understand the deleterious and counterproductive effects of responding to negative thoughts and feelings with worry and rumination. Treatment aims to enable patients to exert greater metacognitive control over their worry and rumination. The positive and negative metacognitive beliefs that keep perseverative thinking in place are modified, using verbal and behavioural reattribution and through specifically designed therapeutic methods.

Trial Locations (1)

L78XP

Royal Liverpool and Broadgreen NHS Trust, Liverpool

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

University of Liverpool

OTHER